دورية أكاديمية

Concomitant use of FSH and low-dose recombinant hCG during the late follicular phase versus conventional controlled ovarian stimulation for intracytoplasmic sperm injection cycles.

التفاصيل البيبلوغرافية
العنوان: Concomitant use of FSH and low-dose recombinant hCG during the late follicular phase versus conventional controlled ovarian stimulation for intracytoplasmic sperm injection cycles.
المؤلفون: Iaconelli, Carla Andrade Rebello, Setti, Amanda Souza, Braga, Daniela Paes Almeida Ferreira, Maldonado, Luiz Guilherme Louzada, Iaconelli Jr, Assumpto, Borges, Edson, Aoki, Tsutomu
المصدر: Human Fertility; Dec2017, Vol. 20 Issue 4, p285-292, 8p
مصطلحات موضوعية: CHORIONIC gonadotropins, BLASTOCYST, COMPARATIVE studies, CONCEPTION, ESTRADIOL, FERTILIZATION in vitro, FOLLICLE-stimulating hormone, MEDICAL care costs, MENSTRUAL cycle, MISCARRIAGE, INDUCED ovulation, OVUM, EMBRYOS, TREATMENT effectiveness, THERAPEUTICS
مستخلص: The objective of this study was to investigate the effects of low-dose hCG supplementation on ICSI outcomes and controlled ovarian stimulation (COS) cost. Three hundred and thirty patients undergoing ICSI were split into groups according to the COS protocol: (i) control group (n = 178), including patients undergoing conventional COS treatment; and (ii) low-dose hCG group (n = 152), including patients undergoing COS with low-dose hCG supplementation. Lower mean total doses of FSH administered and higher mean oestradiol level and mature oocyte rates were observed in the low-dose hCG group. A significantly higher fertilization rate, high-quality embryo rate and blastocyst formation rate were observed in the low-dose hCG group as compared to the control group. The miscarriage rate was significantly higher in the control group compared to the low-dose hCG group. A significantly lower incidence of OHSS was observed in the low-dose hCG group. There was also a significantly lower gonadotropin cost in the low-dose hCG group as compared to the control group ($1235.0 ± 239.0×$1763.0 ± 405.3,p < 0.001). The concomitant use of low-dose hCG and FSH results in a lower abortion rate and increased number of mature oocytes retrieved, as well as improved oocyte quality, embryo quality and blastocyst formation and reduced FSH requirements. [ABSTRACT FROM PUBLISHER]
Copyright of Human Fertility is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14647273
DOI:10.1080/14647273.2017.1303197